Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

Frontiers SARS-CoV-2 variants: Impact on biological and clinical

SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines

A Heterologous Challenge Rescues the Attenuated Immunogenicity of

STAT2 signaling restricts viral dissemination but drives severe

Molecular mechanism of interaction between SARS-CoV-2 and host

Infection- or vaccine mediated immunity reduces SARS-CoV-2

Environmental dissemination of respiratory viruses: dynamic

Pathogens, Free Full-Text

SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node

SARS-CoV-2 infection induces persistent adipose tissue damage in

The Omicron variant is highly resistant against antibody-mediated